HANOVER, Mass (Jan. 11)—Cri-Tech Inc., a division of Immix Technologies L.L.C., and Plasticoid Co. have introduced new high-performance fluoroelastomer compounds for medical components that they say pose strong resistance to chemicals. The durable materials are Federal Drug Administration grade and exhibit good flex fatigue, electrical insulation and temperature resistance characteristics, said Mark C. Stevens, marketing specialist for Cri-Tech. The first commercial application for the fluoroelastomers are bendable rubbers made by Elkton, Md.-based Plasticoid, a manufacturer of molded elastomer products for the medical industry. The bendable rubbers, which were tested to meet USP Class VI requirements, are designed by Plasticoid to house endoscope wiring and are made in various sizes using a proprietary molding process. While the first application of the compounds was produced solely for Plasticoid, Stevens said, Hanover-based Cri-Tech has another generation of FDA-grade materials available. Applications for the product line include flexible tubing for endoscopes and other surgical optical instruments.
Cri-Tech, Plasticoid unveil compounds
Rubber & Plastics News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].